Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | G6PD | P11413 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CCR6 | P51684 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5537841 | 0.87 | HKDC1 (0.46) | CYP2D6CYP2C9CYP2C19ALOX15TP53 | |
| SCHEMBL13295168 | 0.83 | CYP2D6 (0.67) | CYP2D6CYP2C9CYP2C19ALOX15TP53 | |
| SCHEMBL11346014 | 0.81 | CYP2D6 (0.43) | CYP2D6CYP2C9CYP2C19ALOX15TP53 | |
| SCHEMBL11347599 | 0.81 | CYP2D6 (0.43) | CYP2D6CYP2C9CYP2C19ALOX15TP53 | |
| SCHEMBL1245470 | 0.81 | TSHR (0.50) | CYP2D6CYP2C9CYP2C19ALOX15TP53 | |
| SCHEMBL11352276 | 0.81 | CYP3A4 (0.43) | CYP2D6CYP2C9CYP2C19ALOX15TP53 | |
| SCHEMBL9499184 | 0.79 | CYP2D6 (0.49) | CYP2D6CYP2C9CYP2C19ALOX15TP53 | |
| SCHEMBL31666452 | 0.79 | CYP2C9 (0.49) | CYP2D6CYP2C9CYP2C19ALOX15TP53 | |
| SCHEMBL5023082 | 0.79 | CYP2C9 (0.76) | CYP2D6CYP2C9CYP2C19ALOX15TP53 | |
| SCHEMBL1068980 | 0.79 | CYP2C9 (0.49) | CYP2D6CYP2C9CYP2C19ALOX15TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1445019-B1 | Hydroformylation of unsaturated compounds using polymeric phosphite ligands | INVISTA TECH SARL (US) | 2007-03-14 | — | — | EP | claimed |
| EP-1430950-B1 | Hydroformylation of unsaturated compounds using polymeric phosphite ligands | INVISTA TECH SARL (US) | 2006-02-22 | — | — | EP | claimed |
| EP-1225978-B1 | HYDROFORMYLATION OF UNSATURATED COMPOUNDS USING POLYMERIC PHOSPHITE LIGANDS | INVISTA TECH SARL (US) | 2005-03-16 | — | — | EP | claimed |
| US-6855799-B2 | Polymeric phosphite composition and hydrocyanation of unsaturated organic compounds and the isomerization of unsaturated nitriles | INVISTA NORTH AMERICA S.A.R.L. | 2005-02-15 | — | — | US | claimed |
| EP-1445019-A1 | Hydroformylation of unsaturated compounds using polymeric phosphite ligands | INVISTA Technologies S.à.r.l. (US) | 2004-08-11 | — | — | EP | claimed |
| US-6768028-B2 | USING COMPLEX CATALYST CONTAINING GROUP 8 METAL | INVISTA NORTH AMERICA S.A.R.L. | 2004-07-27 | — | — | US | claimed |
| EP-1430950-A1 | Hydroformylation of unsaturated compounds using polymeric phosphite ligands | E.I. du Pont de Nemours and Company (US) | 2004-06-23 | — | — | EP | claimed |
| EP-1216268-B1 | POLYMERIC PHOSPHITE COMPOSITION AND HYDROCYANATION OF UNSATURATED ORGANIC COMPOUNDS AND THE ISOMERIZATION OF UNSATURATED NITRILES | DU PONT (US) | 2003-11-12 | — | — | EP | claimed |
| JP-2003533337-A | — | — | 2003-11-11 | — | — | JP | claimed |
| US-20020177737-A1 | Hydroformylation of unsaturated compounds using polymeric phosphite ligands | INVISTA NORTH AMERICA S.A.R.L. | 2002-11-28 | — | — | US | claimed |
| EP-1225978-A1 | HYDROFORMYLATION OF UNSATURATED COMPOUNDS USING POLYMERIC PHOSPHITE LIGANDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-07-31 | — | — | EP | claimed |
| US-6420611-B1 | GROUP 8 METAL WITH PHOSPHITE POLYMERS FROM POLYHYDRIC ALCOHOL, AMINE AND PHOSPHOCHLOROIDITE | E. I. DU PONT DE NEMOURS AND COMPANY | 2002-07-16 | — | — | US | claimed |
| EP-1216268-A1 | POLYMERIC PHOSPHITE COMPOSITION AND HYDROCYANATION OF UNSATURATED ORGANIC COMPOUNDS AND THE ISOMERIZATION OF UNSATURATED NITRILES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-06-26 | — | — | EP | claimed |
| US-20010049431-A1 | Polymeric phosphite composition and hydrocyanation of unsaturated organic compounds and the isomerization of unsaturated nitriles | INVISTA NORTH AMERICA S.A.R.L. | 2001-12-06 | — | — | US | claimed |
| WO-2001021684-A1 | POLYMERIC PHOSPHITE COMPOSITION AND HYDROCYANATION OF UNSATURATED ORGANIC COMPOUNDS AND THE ISOMERIZATION OF UNSATURATED NITRILES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-03-29 | — | — | WO | claimed |
| WO-2001021308-A1 | HYDROFORMYLATION OF UNSATURATED COMPOUNDS USING POLYMERIC PHOSPHITE LIGANDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-03-29 | — | — | WO | claimed |
| CN-111367143-B | Black resin composition for light shielding film, substrate with light shielding film, color filter and touch screen | 日铁化学材料株式会社 | 2023-10-31 | — | — | CN | disclosed |
| EP-1445019-B1 | Hydroformylation of unsaturated compounds using polymeric phosphite ligands | INVISTA TECH SARL (US) | 2007-03-14 | — | — | EP | disclosed |
| WO-2001021308-A1 | HYDROFORMYLATION OF UNSATURATED COMPOUNDS USING POLYMERIC PHOSPHITE LIGANDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-03-29 | — | — | WO | disclosed |
| EP-0410514-A1 | Polyetherimide-polyamide blend | DSM N.V. (NL) | 1991-01-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020177737-A1 | Hydroformylation of unsaturated compounds using polymeric phosphite ligands | PHOSPHO1, PPIP5K2, PF4 | CYP2D6 3542/4885CYP2C9 3020/4885CYP2C19 3787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.